Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy

Transplant Infectious Disease

Volumn 11, Issue 6, 2009, Pages 549-552

  Zhang, F K ^a   Zhang, Y ^a   Zhang, J Y ^b   Jia, J D ^a   Wang, B E ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Adefovir dipivoxil; De novo hepatitis B infection; Lamivudine; Liver transplantation; Primary biliary cirrhosis

Indexed keywords

ADEFOVIR DIPIVOXIL; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VIRUS DNA;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HUMAN; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MONOTHERAPY; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS REPLICATION;

ADENINE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MIDDLE AGED; PHOSPHONIC ACIDS; TREATMENT OUTCOME;

EID: 71149106234     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00440.x     Document Type: Article

References (19)

1. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004 350 (11) : 1118 1129.
2. Segovia R, Sánchez-Fueyo A, Rimola A, et al. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transpl 2001 7 (2) : 106 112.
3. Crespo J, Fábrega E, Casafont F, et al. Severe clinical course of de novo hepatitis B infection after liver transplantation. Liver Transpl Surg 1999 5 (3) : 175 183.
4. Safadi R, E'id A, Ilan Y, Ashur Y, Jurim O, Shouval D. Natural course of de novo hepatitis B virus infection in liver transplant recipients. Transplant Proc 1997 29 (6) : 2677 2679.
5. Gow PJ, Mutimer DJ. De novo hepatitis B infection acquired during liver transplantation. QJM 2001 94 (5) : 271 275.
6. Prieto M, Gómez MD, Berenguer M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001 7 (1) : 51 58.
7. Fábrega E, García-Suarez C, Guerra A, et al. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach. Liver Transpl 2003 9 (9) : 916 920.
8. Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl 2001 7 (4) : 314 320.
9. Pascasio JM, Aoufi S, Gash A, et al. Response to a vaccination schedule with 4 doses of 40 mug against hepatitis B virus in cirrhotic patients evaluated for liver transplantation. Transplant Proc 2008 40 (9) : 2943 2945.
10. Fabia R, Levy MF, Crippin J, et al. De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg 1998 4 (2) : 119 127.
11. Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg 1997 3 (2) : 105 111.
12. Manns MP, Neuhaus P, Atkinson GF, et al. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study. Transpl Infect Dis 2001 3 (1) : 16 23. (Pubitemid 32148446)
13. Andreone P, Caraceni P, Grazi GL, et al. Lamivudine treatment for acute hepatitis B after liver transplantation. J Hepatol 1998 29 (6) : 985 989.
14. Rayes N, Seehofer D, Hopf U, et al. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation. Transplantation 2001 71 (1) : 96 101.
15. Castells L, Vargas V, Rodríguez F, et al. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transpl 2002 8 (10) : 892 900.
16. Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation. Liver Transpl 2001 7 (2) : 113 117. (Pubitemid 32166516)
17. Schiff ER, Lai CL, Hadziyannis S, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003 38 (6) : 1419 1427.
18. Bárcena R, Del Campo S, Moraleda G, et al. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus. Transplant Proc 2005 37 (9) : 3960 3962.
19. van Nunen AB, de Man RA, Heijtink RA, Vossen AC, Schalm SW. Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue? J Viral Hepat 2002 9 (3) : 221 228.